University of Vermont Cancer Center Member Profile
Rohit Singh, MD
Assistant Professor
Assistant Professor, Division of Hematology & Oncology
Associate Member
Population Sciences and Cancer Outcomes (PSCO)
Academic Interests
I am a medical oncologist specializing in the care of patients with lung cancer, melanoma, and other skin cancers. My research focuses on improving how cancer treatments, particularly immunotherapy are delivered in real-world practice, with an emphasis on reducing treatment-related symptoms and improving quality of life.
I lead and participate in clinical trials and investigator-initiated studies that explore new ways to optimize immunotherapy, including studies focused on fatigue management and treatment timing. I also collaborate on outcomes and health services research to better understand disparities in cancer care and to improve supportive and palliative care integration.
Other Titles, Distinctions and Appointments
June 2023 - June 2025 JCO editorial fellowship, served as an editorial fellow for the JCO journal. Later served as a editorial mentor for multiple physicians across the world (2023- 2025)
I am a medical oncologist specializing in the care of patients with lung cancer, melanoma, and other skin cancers. My research focuses on improving how cancer treatments, particularly immunotherapy are delivered in real-world practice, with an emphasis on reducing treatment-related symptoms and improving quality of life.
I lead and participate in clinical trials and investigator-initiated studies that explore new ways to optimize immunotherapy, including studies focused on fatigue management and treatment timing. I also collaborate on outcomes and health services research to better understand disparities in cancer care and to improve supportive and palliative care integration.
Other Titles, Distinctions and Appointments
June 2023 - June 2025 JCO editorial fellowship, served as an editorial fellow for the JCO journal. Later served as a editorial mentor for multiple physicians across the world (2023- 2025)